FDA Approves Unknown Drug — FLEX PHARMA
**Flex Pharma received FDA approval for NDA217379 on May 29, 2026, a milestone anticipated to unlock significant commercial value and drive a material re-rating of the company’s ma…
SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
**Flex Pharma received FDA approval for NDA217379 on May 29, 2026, a milestone anticipated to unlock significant commercial value and drive a material re-rating of the company’s ma…
HAISCO PHARMACEUTICAL GROUP CO LTD has received FDA approval for its unspecified New Drug Application, setting the stage for a pivotal product launch in May 2026 that is expected t…
# FDA Approves Lupin's Generic Drug Application Lupin Limited received FDA approval for its abbreviated new drug application (ANDA 216095), expanding the company's generic portfol…
The FDA approved Unknown Drug from BIOCON PHARMA under application ANDA220709 on 2026-05-28.
# FDA Approves ANDA for Somerset Therapeutics Somerset Therapeutics LLC has received FDA approval for an abbreviated new drug application (ANDA219529), expanding its generic drug …
Camber Pharmaceuticals received FDA approval for its oral L-Glutamine generic on May 26, 2026, positioning the company to compete in a high-volume therapeutic market. The launch is…
# FDA Approves Generic Clonazepam ANDA for Advagen Pharma Ltd Advagen Pharma Ltd has received FDA approval for its abbreviated new drug application (ANDA216988) for generic clonaz…
# FDA Approves Alembic's Generic Drug Application Alembic has received FDA approval for generic drug application ANDA216370, expanding the company's portfolio in the competitive g…
# FDA Approves New Generic Drug Application for Micro Labs Micro Labs received FDA approval for ANDA220104 on May 19, 2026, expanding its generic pharmaceutical portfolio and posi…
# FDA Approves QUAGEN's ANDA Application, Expanding Generic Drug Portfolio QUAGEN has received FDA approval for ANDA216910, strengthening its position in the generic pharmaceutica…
# FDA Approves Accord BioPharma Biologic; Entry Expected to Intensify Market Competition Accord BioPharma Inc. has received FDA approval for a new biologic therapeutic under BLA76…
# FDA Approves Jubilant Generics ANDA Application Jubilant Generics received FDA approval for ANDA210329 on May 15, 2026, positioning the company to capture market share in the ge…
# FDA Approves Dr. Reddy's Generic Drug Application Dr. Reddy's Laboratories has received FDA approval for ANDA214733, expanding its generic pharmaceutical portfolio and positioni…
Zydus Lifesciences announced that FDA has granted approval for its generic drug submission referenced by ANDA217758, potentially impacting the market share of the branded equivalen…
# FDA Approves Amneal Pharmaceuticals' Generic Tretinoin Topical Formulation Amneal Pharmaceuticals NY LLC received FDA approval for its generic tretinoin topical formulation (AND…
# FDA Approves Renova Pharmaceuticals' Generic L-Glutamine Oral Formulation Renova Pharmaceuticals LLC has received FDA approval for its generic L-glutamine oral formulation (ANDA…
# FDA Approves Chiesi's New Drug Application NDA219622 Chiesi Pharmaceuticals has received FDA approval for a new drug candidate under application NDA219622, marking an addition t…
Ionetix Corporation announced the FDA approval of Gallium Ga-68 Gozetotide, a generic version of the prostate cancer imaging agent PSMA-11, which is expected to intensify price com…
# FDA Approves Estradiol Transdermal Patch from Encube Ethicals Encube Ethicals, Inc. received FDA approval for its generic estradiol transdermal patch (ANDA218214), expanding the…
# FDA Approves Micro Labs Generic Drug Application Micro Labs has received FDA approval for its abbreviated new drug application (ANDA 218558), expanding the company's generic pha…